CTUK - CT PROGRESSIVE INCOME PLC

Portfolio Update

· RNS

Summary

CT UK Capital and Income Investment Trust PLC, as of December 31, 2024, has a top ten holdings concentration of 45.5%, with Intermediate Capital at 5.8% and AstraZeneca at 5.3%. The sector breakdown shows 28.6% in Financials, followed by Consumer Discretionary at 15.9%. The net gearing is 7.1%.

Announcement

RNS Number : 2993U
CT UK Capital and Income Investment
22 January 2025
 

CT UK CAPITAL AND INCOME INVESTMENT TRUST PLC

 

Legal Entity Identifier: 21380052ETTRKV2A6Y19

 

 

All data as at 31 December 2024   

 

This data is available on the Company's website ctcapitalandincome.co.uk

 

Top Ten Holdings

%

Intermediate Capital

5.8

AstraZeneca

5.3

OSB Group

5.2

RELX

5.1

Unilever

5.1

Beazley

4.5

LondonMetric Property

4.0

Legal & General Group

3.6

Burford Capital

3.5

Rio Tinto

3.4

Total

45.5

 

Sector Breakdown

%

Financials

 28.6

Consumer Discretionary

 15.9

Industrials

 15.0

Consumer Staples

 10.3

Health Care

 8.8

Utilities

 5.4

Real Estate

 5.2

Energy

 4.8

Basic Materials

 3.4

Telecommunications

 1.6

Technology

 1.0

Total

100.0

 

 

Note: All percentages are based on Gross Assets

 

Net Gearing

7.1%

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUBLLFLEFLBBBF